US58463J3041 - REIT

Taking everything into account, **MPW** scores **3** out of 10 in our fundamental rating. **MPW** was compared to 129 industry peers in the **Diversified REITs** industry. Both the profitability and financial health of **MPW** have multiple concerns. **MPW** is valued expensive and it does not seem to be growing.

In the past year **MPW** had a positive cash flow from operations.

Each year in the past 5 years **MPW** had a positive operating cash flow.

With a **Return On Assets** value of **-10.77%**, **MPW** is not doing good in the industry: **98.43%** of the companies in the same industry are doing better.

The **Return On Equity** of **MPW** (**-28.19%**) is worse than **95.28%** of its industry peers.

The **Return On Invested Capital** of **MPW** (**1.17%**) is worse than **85.04%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -10.77% | ||

ROE | -28.19% | ||

ROIC | 1.17% |

ROA(3y)1.57%

ROA(5y)1.97%

ROE(3y)3.64%

ROE(5y)4.41%

ROIC(3y)2.9%

ROIC(5y)3.2%

The **Operating Margin** of **MPW** (**31.85%**) is better than **69.29%** of its industry peers.

In the last couple of years the **Operating Margin** of **MPW** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 31.85% | ||

PM (TTM) | N/A | ||

GM | 96.91% |

OM growth 3Y-48%

OM growth 5Y-33.49%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.88%

GM growth 5Y-0.6%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **MPW** is destroying value.

The number of shares outstanding for **MPW** has been increased compared to 1 year ago.

Compared to 1 year ago, **MPW** has a worse debt to assets ratio.

Looking at the **Altman-Z score**, with a value of **0.10**, **MPW** is doing worse than **77.95%** of the companies in the same industry.

The Debt to FCF ratio of **MPW** is **56.21**, which is on the high side as it means it would take **MPW**, **56.21** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **1.51** is on the high side and indicates that **MPW** has dependencies on debt financing.

With a **Debt to Equity ratio** value of **1.51**, **MPW** is not doing good in the industry: **65.35%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.51 | ||

Debt/FCF | 56.21 | ||

Altman-Z | 0.1 |

ROIC/WACC0.22

WACC5.29%

A Current Ratio of **2.09** indicates that **MPW** has no problem at all paying its short term obligations.

The **Current ratio** of **MPW** (**2.09**) is better than **77.17%** of its industry peers.

The **Quick ratio** of **MPW** (**2.09**) is better than **77.95%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.09 | ||

Quick Ratio | 2.09 |

The earnings per share for **MPW** have decreased strongly by **-2428.57%** in the last year.

Measured over the past years, **MPW** shows a very negative growth in **Earnings Per Share**. The EPS has been decreasing by **-18.94%** on average per year.

The Revenue for **MPW** has decreased by **-43.50%** in the past year. This is quite bad

Measured over the past years, **MPW** shows a small growth in **Revenue**. The Revenue has been growing by **2.13%** on average per year.

EPS 1Y (TTM)-2428.57%

EPS 3Y-24.4%

EPS 5Y-18.94%

EPS Q2Q%-805.26%

Revenue 1Y (TTM)-43.5%

Revenue growth 3Y-11.3%

Revenue growth 5Y2.13%

Sales Q2Q%-26.34%

The **Earnings Per Share** is expected to decrease by **-10.71%** on average over the next years. This is quite bad

Based on estimates for the next years, **MPW** will show a decrease in **Revenue**. The Revenue will decrease by **-5.95%** on average per year.

EPS Next Y-596.34%

EPS Next 2Y-12.06%

EPS Next 3Y-10.71%

EPS Next 5YN/A

Revenue Next Year-20.85%

Revenue Next 2Y-13.1%

Revenue Next 3Y-7.38%

Revenue Next 5Y-5.95%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings Ratio** is negative for **MPW**. In the last year negative earnings were reported.

With a **Price/Forward Earnings** ratio of **18.36**, **MPW** is valued on the expensive side.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **MPW** indicates a rather cheap valuation: **MPW** is cheaper than 96.85% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 18.36 |

Based on the **Enterprise Value to EBITDA** ratio, **MPW** is valued expensively inside the industry as 80.31% of the companies are valued cheaper.

Based on the **Price/Free Cash Flow** ratio, **MPW** is valued cheaply inside the industry as 84.25% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 17.9 | ||

EV/EBITDA | 20.1 |

A cheap valuation may be justified as **MPW**'s earnings are expected to decrease with **-10.71%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-12.06%

EPS Next 3Y-10.71%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.05% |

The dividend of **MPW** has a limited annual growth rate of **0.77%**.

Dividend Growth(5Y)0.77%

Div Incr Years0

Div Non Decr Years0

The earnings of **MPW** are negative and hence is the payout ratio. **MPW** will probably not be able to sustain this dividend level.

DP-25.66%

EPS Next 2Y-12.06%

EPS Next 3Y-10.71%

**MEDICAL PROPERTIES TRUST INC**

NYSE:MPW (11/8/2024, 3:50:08 PM)

**4.97**

**+0.43 (+9.47%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.98B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.05% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 18.36 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -10.77% | ||

ROE | -28.19% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 31.85% | ||

PM (TTM) | N/A | ||

GM | 96.91% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.51 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.09 | ||

Quick Ratio | 2.09 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-2428.57%

EPS 3Y-24.4%

EPS 5Y

EPS Q2Q%

EPS Next Y-596.34%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-43.5%

Revenue growth 3Y-11.3%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y